STOK earnings: real EPS beat/miss history, analyst consensus Buy, P/E -10.23. Updated 2026-07-23.
Stoke Therapeutics (STOK) Research Hub
Stoke Therapeutics (STOK) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 29.03 USD (-2.97%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.23, market cap 1.74B. This hub links to the full technical, earnings and options research available for STOK.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 29.03 USD (-2.97%) |
| 52-week range | 27.4 USD – 33.94 USD |
| Trend regime | Range |
| 14-day RSI | 32.4 (Bearish) |
| Trailing P/E | -10.23 |
| Market cap | 1.74B |
| Dividend yield | 0.00% |
Available research for STOK
Covered Call on STOK: how it works, illustrative setup around the real 29.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on STOK: how it works, illustrative setup around the real 29.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on STOK: how it works, illustrative setup around the real 29.03 USD price, max profit/loss, breakeven and when to use it. Educational.
STOK technical analysis: range, last 29.03 USD, RSI 32.4, 52w range 27.4 USD–33.94 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is STOK in?
Stoke Therapeutics (STOK) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is STOK in an uptrend or downtrend?
As of 2026-09-11, STOK is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is STOK's trailing P/E ratio?
STOK's trailing P/E is -10.23, with a market cap of 1.74B. See the earnings research page for full valuation detail.